Rhythm Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Clinical Trials Biotech Investing
CMS Grants Progenics New Technology Add-On Payment for Inpatient Use of AZEDRA Pharmaceutical Investing
Green Growth Brands Celebrates Opening More Than 100 CBD Shops In Seven Months Cannabis Investing News
Relevium Announces Record Sales From the Bioganix® Brand and Provides CBD Update Cannabis Investing News
Green Growth Brands Announces Acquisition Closing of Florida-Based Spring Oaks Cannabis Investing News
FSD Pharma Appoints Larry Kaiser, MD, FACS, Dean, Lewis Katz School of Medicine at Temple University as Chairman of Its Scientific Advisory Board Cannabis Investing News
Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis in a Recent Idiopathic Pulmonary Fibrosis Study by 56% Life Science Investing
Life Science Big News Roundup: Lexaria and Hill Street Enter Global Manufacturing & Licensing Partnership; Cardiol to Present at Canaccord Genuity 39th Annual Growth Conference Life Science Investing
Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union Pharmaceutical Investing
Cardiol Therapeutics to Present at Canaccord Genuity 39th Annual Growth Conference Cannabis Investing News
